Label Changes: Hympavzi (marstacimab-hncq)
A drug's label (its prescribing information) is revised many times after approval: new warnings, new uses, new doses. DailyMed keeps every version. Pick a drug to see them all and what changed between any two.
Every version of the Hympavzi label DailyMed has published, from Pfizer Laboratories Div Pfizer Inc, and what changed between any two of them, section by section. Current label on DailyMed.
- Versions on DailyMed: 8
- Sections changed, version 7 to 8: 10, Including the boxed warning
- Boxed warningNew section · 52 words added
- Dosage and administrationChanged · 3 words added
- Warnings and precautionsChanged · 217 words added, 115 removed
- Use in specific populationsChanged · 1 removed
- Patient counseling informationChanged · 124 words added, 59 removed
- Patient informationChanged · 47 words added, 5 removed
- PRINCIPAL DISPLAY PANEL – 150 mg/mL Prefilled PenChanged · 1 word added, 1 removed
- PRINCIPAL DISPLAY PANEL – 150 mg/mL Prefilled Pen CartonChanged · 1 removed
- PRINCIPAL DISPLAY PANEL - 150 mg/mL Prefilled SyringeChanged · 1 word added, 1 removed
- PRINCIPAL DISPLAY PANEL - 150 mg/mL Prefilled Syringe CartonChanged · 1 removed
Boxed warning
New section52 words addedDosage and administration
Changed3 words addedWarnings and precautions
Changed217 words added, 115 removedUse in specific populations
Changed1 removedPatient counseling information
Changed124 words added, 59 removedPatient information
Changed47 words added, 5 removedPRINCIPAL DISPLAY PANEL – 150 mg/mL Prefilled Pen
Changed1 word added, 1 removedPRINCIPAL DISPLAY PANEL – 150 mg/mL Prefilled Pen Carton
Changed1 removedPRINCIPAL DISPLAY PANEL - 150 mg/mL Prefilled Syringe
Changed1 word added, 1 removedPRINCIPAL DISPLAY PANEL - 150 mg/mL Prefilled Syringe Carton
Changed1 removedUnchanged: Indications and usage, Dosage forms and strengths, Contraindications, Adverse reactions, Drug interactions, Overdosage, Description, Clinical pharmacology, Nonclinical toxicology, Clinical studies, How supplied, Instructions for use, PRINCIPAL DISPLAY PANEL – 75 mg/0.5 mL Prefilled Pen, PRINCIPAL DISPLAY PANEL – 75 mg/0.5 mL Prefilled Pen Carton, PRINCIPAL DISPLAY PANEL – 75 mg/0.5 mL Prefilled Syringe, PRINCIPAL DISPLAY PANEL – 75 mg/0.5 mL Prefilled Syringe Carton.
| Version | Published on DailyMed | Compare | SPL file |
|---|---|---|---|
| 8 | Nov 16, 2026 | Shown below | Download .zip |
| 7 | Jun 23, 2026 | With version 6 | Download .zip |
| 6 | Jun 17, 2026 | With version 5 | Download .zip |
| 5 | Dec 22, 2025 | With version 4 | Download .zip |
| 4 | Nov 17, 2025 | With version 3 | Download .zip |
| 3 | Sep 29, 2025 | With version 2 | Download .zip |
| 2 | Feb 12, 2025 | With version 1 | Download .zip |
| 1 | Nov 7, 2024 | First version | Download .zip |
Open an SPL label file
Drop a Structured Product Labeling .xml file, or the .zip DailyMed downloads, to read it as a label. It is read in this browser tab and not uploaded.
Versions and label text from DailyMed's SPL web services; a version's text is read from its SPL file, so it matches what DailyMed shows. Recent safety-related changes from FDA's Safety-related Labeling Changes database, which covers NDAs and CDER biologics, not generics. Lists refresh daily. DailyMed, National Library of Medicine
About label change history
How to read a comparison
Sections that changed come first, in the order a reviewer reads a label: boxed warning, recent major changes, indications, dosage, contraindications, warnings and precautions, adverse reactions, then the rest. Each shows the changed lines with one unchanged line either side; longer unchanged stretches are folded into a count. Table rows read left to right with cells separated by a bar.
The comparison covers the label text. Images, product data (NDC codes, ingredients, packaging) and formatting are not compared.
Which label is shown
A drug can have several labels: one per brand-name application (Ozempic, Wegovy and Rybelsus are three), and copies from repackagers. For each NDA or BLA the page takes the DailyMed set with the most versions, which is the application holder's. Generic labels are left out; they follow the brand's label.
Frequently asked questions
- Where do the versions come from?
- DailyMed, the National Library of Medicine's library of labels in Structured Product Labeling (SPL) format. Each time a company submits a revised label, DailyMed publishes it as a new version of the same set and keeps the old ones.
- Is a new version a new FDA approval?
- Not always. Companies also submit new versions for changes that need no FDA approval first, such as a new address, a new package size or a corrected typo. Safety changes FDA approved are listed in its Safety-related Labeling Changes database, linked below.
- Why does the published date differ from the label's revised date?
- The published date is when DailyMed posted the version. The label's own revised date, at the end of the highlights, is when the company revised the text, usually a few days to weeks earlier.
- How is the comparison made?
- Each section is matched by its standard LOINC code, then split into headings, paragraphs, list items and table rows. Lines are aligned with a longest-common-subsequence diff; a removed and an added line that share at least half their words are shown as one edited line with the changed words marked. Curly quotes, dash styles and spacing are ignored.
- Is my SPL file uploaded?
- No. A file you drop on this page is read in your browser tab and never sent to Arca.